- Home
- ROIV vs DBX Comparison
ROIV vs DBX Comparison
Compare ROIV & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- DBX
- Stock Information
- Founded
- ROIV 2014
- DBX 2007
- Country
- ROIV United Kingdom
- DBX United States
- Employees
- ROIV N/A
- DBX N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- DBX Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- DBX Technology
- Exchange
- ROIV Nasdaq
- DBX Nasdaq
- Market Cap
- ROIV 8.4B
- DBX 8.2B
- IPO Year
- ROIV N/A
- DBX 2018
- Fundamental
- Price
- ROIV $10.79
- DBX $28.91
- Analyst Decision
- ROIV Buy
- DBX Buy
- Analyst Count
- ROIV 4
- DBX 4
- Target Price
- ROIV $17.50
- DBX $31.00
- AVG Volume (30 Days)
- ROIV 5.9M
- DBX 3.7M
- Earning Date
- ROIV 05-29-2025
- DBX 05-08-2025
- Dividend Yield
- ROIV N/A
- DBX N/A
- EPS Growth
- ROIV N/A
- DBX 1.18
- EPS
- ROIV N/A
- DBX 1.48
- Revenue
- ROIV $122,585,000.00
- DBX $2,541,600,000.00
- Revenue This Year
- ROIV N/A
- DBX N/A
- Revenue Next Year
- ROIV N/A
- DBX N/A
- P/E Ratio
- ROIV N/A
- DBX $19.48
- Revenue Growth
- ROIV 140.04
- DBX 0.79
- 52 Week Low
- ROIV $8.73
- DBX $20.68
- 52 Week High
- ROIV $13.06
- DBX $33.33
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- DBX 54.41
- Support Level
- ROIV $10.58
- DBX $29.04
- Resistance Level
- ROIV $11.77
- DBX $30.40
- Average True Range (ATR)
- ROIV 0.34
- DBX 0.68
- MACD
- ROIV -0.07
- DBX -0.01
- Stochastic Oscillator
- ROIV 17.65
- DBX 37.00
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.